Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)

Soluble RAGE and malondialdehyde in type 1 diabetes patients without chronic complications during the course of the disease

(2012) Janice S Reis et al.   Diabetes & Vascular Disease Research

Relationship of Soluble RAGE and RAGE Ligands HMGB1 and EN-RAGE to Endothelial Dysfunction in Type 1 and Type 2 Diabetes Mellitus

(2012) J. Škrha Jr et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS)

(2011) Barry I. Hudson et al.   ATHEROSCLEROSIS

RAGE biology, atherosclerosis and diabetes

(2011) Drazenka Pongrac Barlovic et al.   CLINICAL SCIENCE

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial

(2011) H. M. Colhoun et al.   DIABETES

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes

(2011) M. C. Thomas et al.   DIABETOLOGIA

Association Between Serum Levels of the Soluble Receptor (sRAGE) for Advanced Glycation Endproducts (AGEs) and their Receptor (RAGE) in Peripheral Blood Mononuclear Cells of Children with Type 1 Diabetes Mellitus

(2011) A. Dettoraki et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes

(2010) Johanna W.M. Nin et al.   DIABETES

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

(2009) H.L. Tam et al.   ATHEROSCLEROSIS

RAGE: a novel biological and genetic marker for vascular disease

(2009) Anastasia Z. Kalea et al.   CLINICAL SCIENCE

Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms

(2009) N. Grossin et al.   DIABETES & METABOLISM

Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications

(2009) Jason B Lindsey et al.   Diabetes & Vascular Disease Research

Soluble forms of RAGE in internal medicine

(2009) Natale Vazzana et al.   Internal and Emergency Medicine

Calcium-regulated intramembrane proteolysis of the RAGE receptor

(2008) Arnaud Galichet et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients

(2008) Naoto Katakami et al.   Diabetes & Vascular Disease Research

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

(2008) Angela Raucci et al.   FASEB JOURNAL

Identification, classification, and expression of RAGE gene splice variants

(2007) Barry I. Hudson et al.   FASEB JOURNAL